CUMT Contact Us 中文 search

    Seminars

    CUMT SEM · Entrepreneur Forum (7) Strategic R&D Considerations in the Pharmaceutical Industry Under Centralized Procurement

    Published on: June 20, 2024 Views:

    Lecture: Strategic R&D Considerations in the Pharmaceutical Industry Under Centralized Procurement


    Speaker: Wu Shibin

    • Global Partner, Fosun Group

    • Vice President, Fosun Pharma


    Time: June 29, 16:00–18:00


    Venue: Room B108, SEM


    Host: Professor Jiang Hongyan, Vice Dean, SEM

     

    About the Speaker:

    Wu Shibin is a Global Partner at Fosun Group and Vice President of Fosun Pharma. A senior researcher-level engineer, he holds EMBA degrees from Saint Joseph's University in the United States and CEIBS (China Europe International Business School).

    Professional Roles:

    • Vice President, China Biochemical Pharmaceutical Industry Association

    • Vice President, China Pharmaceutical Quality Association

    • Vice President, Jiangsu Pharmaceutical Industry Association

    • Vice President, Jiangsu Chief Quality Officer Association

    • Member of the Xuzhou CPPCC

    • Consultant to the Xuzhou Municipal Government

    With 35 years of experience in the pharmaceutical industry, Mr. Wu formerly served as Chairman and CEO of Jiangsu Wanbang Biopharmaceutical Group. Under his leadership, Wanbang Pharma became a national leader in diabetes treatment, integrating R&D, production, and marketing.

    Honors and Awards:

    • "Xuzhou Economic Person of the Year"

    • "China Torch Jiangsu Entrepreneurship Mentor"

    • "Jiangsu Province Quality Expert"

    • "Jiangsu Province Model Worker"

    • "Jiangsu Province Outstanding Entrepreneur"